IP Library Granted Patent US 7,524,936
Granted Patent B2
US 7,524,936 · App. 11/712,222 · Granted Apr 28, 2009

Mitogenic oxygenase regulators

Assignee: Emory University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,524,936
App. No.
11/712,222
Granted
Apr 28, 2009
Kind
B2
Abstract

The present invention relates to new genes encoding for the production of novel nox enzyme proteins involved in generation of reactive oxygen intermediates that affect cell division. The present invention also provides vectors containing these genes, cells transfected with these vectors, antibodies raised against these novel proteins, kits for detection, localization and measurement of these genes and proteins, and methods to determine the activity of drugs to affect the activity of the proteins of the present invention.

Claims (14)

1. An isolated antibody, wherein the antibody specifically binds a polypeptide consisting of the amino acid sequence of SEQ ID NO: 4, a fragment of the amino acid sequence of SEQ ID NO: 4 comprising the flavoprotein domain, or a substitution of SEQ ID NO: 4 of less than 1% of the amino acid sequence comprising the flavoprotein domain.

2. The isolated antibody of claim 1 , wherein the antibody specifically binds the amino acid sequence set forth as SEQ ID NO:4.

3. The isolated antibody of claim 1 , wherein the antibody is a monoclonal antibody.

4. The isolated antibody of claim 1 , wherein the antibody is a polyclonal antibody.

5. The isolated antibody of claim 1 , wherein the antibody is labeled.

6. The isolated antibody of claim 1 , wherein the label is a radiolabel, a dye, a magnetic particle, biotin, avidin, a fluorescent molecule, a chemiluminescent molecule, ferritin, a cytotoxin or colloidal gold.

7. A method for detecting a protein, comprising

contacting a sample with the antibody of claim 1 ; and

detecting binding of the antibody to a protein comprising the amino acid sequence of SEQ ID NO: 4, a fragment of SEQ ID NO: 4 comprising the flavoprotein domain, or a substitution of SEQ ID NO: 4 of less than 1% of the amino acid sequence comprising the flavoprotein domain wherein the protein is capable of superoxide production, thereby detecting the protein.

8. The method of claim 7 , wherein the sample is a cell, cellular extract, tissue, tissue extract, biopsy or biological fluid.

9. The method of claim 7 , wherein the antibody is a polyclonal antibody.

10. The method of claim 7 , wherein the antibody is a monoclonal antibody.

11. The method of claim 7 , wherein the antibody is labeled.

12. The method of claim 11 , wherein the antibody is labeled with a dye, a magnetic particle, biotin, avidin, a fluorescent molecule, a chemiluminescent molecule, ferritin, or colloidal gold.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 28, 2010
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024454/0351 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2009
From: LAMBETH, J. DAVID; CHENG, GUANGJIE
To: EMORY UNIVERSITY
Reel/Frame 022402/0394 →
Continuity (7)
Division 1085006000 · May 20, 2004
Continuation 0999924800 · Nov 15, 2001
Provisional Application 6028917200 · May 7, 2001
Provisional Application 6028953700 · May 7, 2001
Provisional Application 6025136400 · Dec 5, 2000
Provisional Application 6024930500 · Nov 16, 2000
Related Publication 20070190576A1 · Aug 16, 2007